A Study on Uric Acid Levels in Non Diabetic Patients at a Tertiary Care Hospital
DOI:
https://doi.org/10.48165/2bspgb09Keywords:
Hyperuricemia, Nondiabetic, CreatinineAbstract
Background: The pathophysiology of diabetic nephropathy is complex and still not fully elucidated. Observational studies suggest a relationship of UA level with incident CKD, but studies evaluating the relationship with decline in kidney function in established CKD are conflictingSeveral prospective studies have suggested that hyperuricemia is associated with an increased risk of incident cardiovascular events and death in both nondiabetic and type 2 diabetic individuals Hyperuricemia also is largely prevalent in patients with chronic kidney disease(CKD). Subjects and Methods: The patients were randomly divided into two groups according group chosen by time of enrollment. By using simple random method, 64 study subjects will be taken, and the study subject is divided into 2 groups. A detailed history, anthropometry, vital signs, clinical examination and laboratory parameters were recorded for both the study group. Results: The Study reveals that, there was no statistical significant difference of mean serum uric acid among smokers and non-smokers in non-diabetes patients with CKD (P>0.05).Study reveals that, there was no statistical significant difference of mean serum uric acid among alcoholic and non-alcoholic cases in non-diabetes patients with CKD (P>0.05). Conclusion: non-diabetic patients with CKD cases (P<0.05). There was an increasing trend in the mean serum creatinine concentration with a corresponding decreasing trend in eGFR across increasing UA categories There is significantly sloping down of GFR with increase of SUA level as model.
References
1. William S. Waring and ShahanaEsmail. How Should Serum Uric Acid Concentrations be interpreted in Patients with Hypertension?
Current Hypertension Reviews, 2005, 1, 89-95.
2. Richard J. Johnson, Duk-Hee Kang, Daniel Feig, Salah Kivlighn, John Kanellis, Susumu Watanabe, et al. Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease? Hypertension. 2003; 41:1183-1190.
3. Melvin R Hayden and Suresh C Tyagi. Uric acid: A new look at an old risk marker forcardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutrition & Metabolism 2004, 1:10
4. Berne M. The role of adenosine in the regulation of coronary blood flow. Circulation Res, 1980; 47:807–13.
5. NKF/DOQI™ N.K.F. (2002) Clinical practice guidelines for chronic kidney disease.American Journal of Kidney Diseases, S1 - S266. 6. Levin A. (2003) The advantage of a uniform terminology and staging system for chronic kidney disease (CKD). Nephrol Dial Transplant
18, 1446-1451
7. Joanne Bargman, Karl Skorecki. Harrison's principle of Internal medicine, 19th Edition, Chapter 335 Chronic Kidney Didease, p 1811.).
8. Sathiya, R et al. “A Comparative Study of Serum Uric Acid levels and Lipid Ratios in Coronary Artery Disease Patients” International journal of biomedical science : IJBS vol. 10,2 (2014): 124-8.
9. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992:National Health and Nutrition Examination Survey. JAMA 2000;283:2404– 2410.
10. Anupama YJ, Uma G. Prevalence of chronic kidney disease among adults in a rural community in South India: Results from the kidney disease screening (KIDS) project. Indian J Nephrol. 2014;24(4):214- 21.
